Last edition
News about Clinical Trials
Phastar and Beaconcure to Deliver Process Revolution in Clinical Data Review
Beaconcure Inc. has inked a strategic partnership with Phastar Inc. to enhance clinical review processes in clinical trials.
Clinical Trials | 21/05/2024 | By Aishwarya | 339
MetP Pharma Announces Preclinical Research Results of semaglutide Development
MetP Pharma has announced its preclinical research results that strongly support the further development of semaglutide in an oleogel formulation using the BrainDos drug delivery technology.
Clinical Trials | 09/05/2024 | By Aishwarya | 724
Acumen Announces First Patient Dosed in ALTITUDE-AD
Acumen Pharmaceuticals, Inc. has announced that the first patient has been dosed with sabirnetug (ACU193) in the ALTITUDE-AD Phase 2 clinical trial designed to evaluate the clinical efficacy and safety of sabirnetug in patients with early AD.
Clinical Trials | 08/05/2024 | By Aishwarya | 539
Pepper Bio to Gain Exclusive Rights for Clinical Development of Lerociclib
G1 Therapeutics, Inc. has inked a global licensing agreement (excluding the Asia-Pacific region) with Pepper Bio for lerociclib for all indications except for certain radioprotectant uses.
Clinical Trials | 03/05/2024 | By Aishwarya | 583
Parexel Join Hands with Palantir to Boost Clinical Data Delivery for Patients
Parexel has forged a multi-year strategic partnership with Palantir Technologies Inc. to leverage AI to help enhance and accelerate the delivery of safe and effective clinical trials for the world’s biopharmaceutical customers.
Clinical Trials | 29/04/2024 | By Aishwarya | 1453
Shuttle Pharmaceuticals Completes Manufacturing of Active Pharmaceutical Ingredient (API) for Use in Clinical Trial
Clinical Trials | 04/08/2023 | By Sudeep Soparkar | 621
The new business will offer pharmaceutical development services, including sterile fill-finish
Clinical Trials | 07/09/2022 | By Sudeep Soparkar | 771
3D model created for rare neuromuscular disorder
Scientists have created a bioengineered 3-D model that mimics the biology of two rare diseases. The researchers used the 'tissue chip' model to show how a drug could potentially treat the diseases, providing data for a drug company's FDA submission for authorization for clinical testing.
Clinical Trials | 04/05/2022 | By Sudeep Soparkar | 801
New patent grant to OSE Immunotherapeutics by EPO
OSE Immunotherapeutics receives European patent covering novel myeloid immune checkpoint target, CLEC-1 for cancer treatment
Clinical Trials | 03/05/2022 | By Sudeep Soparkar | 930
EMA reviews gene therapy for Haemophilia B
EMA (European Medicines Agency) has started reviewing the CSL Behring's MAA for gene therapy etranacogene dezaparvovec (EtranaDez), for the patients getting treatment for Haemophila B.
Clinical Trials | 28/04/2022 | By Sudeep Soparkar | 914
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy